CorMedix Inc. to Acquire Assets of Heron Therapeutics, Inc. in $145 Million Deal
Acquiring Company
CorMedix
Acquired Company
Heron Therapeutics
Berkeley HeightsSan DiegoBiotechnologyHealth CareTherapeuticsDescription
On November 8, 2026, Heron Therapeutics entered into an Asset Purchase Agreement with CorMedix Inc. As part of the agreement, CorMedix will acquire substantially all assets of Heron for $145 million in cash, along with additional stock and royalties based on future sales. The acquisition aims to enhance CorMedix's product offerings and strengthen its market position.
Who to call at CorMedix, and when
When CorMedix changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CorMedix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CorMedix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CorMedix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CorMedix makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Heron Therapeutics?
Heron Therapeutics was acquired by CorMedix, based in Berkeley Heights. The deal was reported on November 9, 2026. CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is publicly traded (CRMD) and operates in Biotechnology.
When did CorMedix acquire Heron Therapeutics?
CorMedix's acquisition of Heron Therapeutics was reported on November 9, 2026. On November 8, 2026, Heron Therapeutics entered into an Asset Purchase Agreement with CorMedix Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Heron Therapeutics do?
At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter. It is privately held, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.